Neothetics
Company

Last deal

$8M

Amount

Series C

Stage

11.02.2014

Date

3

all rounds

$35.3M

Total amount

Financing round

General

About Company
Neothetics is a clinical-stage specialty pharmaceutical company focused on developing therapeutics for the aesthetic market.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Lithera

Number of employees

Last funding type

Series C

IPO status

Private

Description

The company's flagship product, LIPO-202, is a non-surgical injection that can reduce abdominal bulging in non-obese patients in under five minutes with no downtime, making it a potential best-in-class solution for localized fat reduction and body contouring.
Contacts

Phone number

Social url

Similar Companies
999
Eirion Therapeutics

Eirion Therapeutics

Eirion Therapeutics develops prescription products for aesthetic dermatology.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Woburn, MA, USA

total rounds

2

total raised

$40M
RENOVION

RENOVION

RENOVION is a clinical stage pharmaceutical company specializing in nebulized therapy.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Pharmaceuticals

Location

Chapel Hill, NC, USA

total rounds

7

total raised

$29.38M
Cassiopea

Cassiopea

Cassiopea is a clinical-stage specialty pharmaceutical company developing innovative dermatology products.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Keywords

Health Care, Biotechnology, Medical

Location

Lainate, Metropolitan City of Milan, Italy
Achelios Therapeutics

Achelios Therapeutics

Achelios Therapeutics is a pharmaceutical development company that creates new products through preclinical and early clinical POC.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Durham, NC, USA

total rounds

2

total raised

$3.52M
M&A Details
1

Acquired by

Evofem Biosciences

announced date

17.01.2018

Financials

Funding Rounds
4
3

Number of Funding Rounds

$35.3M

Money Raised

Their latest funding was raised on 11.02.2014. Their latest investor RusnanoMedInvest. Their latest round Series C

Date 
Funding Round 
Investors 
Money Raised 
Lead 
11.02.2014
3
$8M
18.07.2013
3
$6.7M
19.12.2012
5
$20.6M
RusnanoMedInvest

RusnanoMedInvest

RusnanoMedInvest is a Moscow-based venture capital firm specializing in innovative developments in pharmaceuticals and biotechnology.

Sector

Open End and Miscellaneous Investment Vehicles

Subsector

Open End and Miscellaneous Investment Vehicles

Location

Moscow, Russia

count Of Investments

3

count Of Exists

2
Co-Investors
Investors
8
1

Number of lead investors

8

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Series C
No
Series C
No
Series C
RusnanoMedInvest

RusnanoMedInvest

RusnanoMedInvest is a Moscow-based venture capital firm specializing in innovative developments in pharmaceuticals and biotechnology.

Sector

Open End and Miscellaneous Investment Vehicles

Subsector

Open End and Miscellaneous Investment Vehicles

Location

Moscow, Russia

count Of Investments

3

count Of Exists

2
Alta Partners

Alta Partners

Alta Partners is a venture capital firm investing in healthcare and life sciences.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

San Francisco, CA, USA

count Of Investments

201

count Of Exists

55
Domain Associates

Domain Associates

Domain Associates is a venture capital firm that invests exclusively in life sciences.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

San Diego, CA, USA

count Of Investments

241

count Of Exists

65

People

Employee Profiles
3
Susan Knudson

Susan Knudson

Chief Financial Officer

Activity

Recent News
0